Paroxysmal Nocturnal Hemoglobinuria Associated Cutaneous Thrombosis: A Case Report. [PDF]
Sangwan P +5 more
europepmc +1 more source
Advances in Complement Inhibition Therapies for Paroxysmal Nocturnal Hemoglobinuria and Autoimmune Hemolytic Disorders. [PDF]
Tamdin T, Rodgers GM.
europepmc +1 more source
Successful Control of Chemotherapy-Induced Breakthrough Hemolysis With Ravulizumab in a Patient With Paroxysmal Nocturnal Hemoglobinuria During Carboplatin-Pemetrexed Treatment for Lung Adenocarcinoma. [PDF]
Takahata A, Tanaka K, Toyota S.
europepmc +1 more source
Integrative miRNA-mRNA Network and Molecular Dynamics-Based Identification of Therapeutic Candidates for Paroxysmal Nocturnal Hemoglobinuria. [PDF]
Zhao P +8 more
europepmc +1 more source
Case Report: Iptacopan in a paroxysmal nocturnal hemoglobinuria patient with severe renal insufficiency. [PDF]
Wu T, Wang X.
europepmc +1 more source
Two Cases of Crovalimab-Induced Platelet Recovery in Bone Marrow Failure-Associated Paroxysmal Nocturnal Hemoglobinuria (PNH). [PDF]
Onaka T, Yamada Y, Imada K.
europepmc +1 more source
Efficacy and Safety Maintained up to 3 Years in Adults with Paroxysmal Nocturnal Hemoglobinuria Receiving Pegcetacoplan. [PDF]
de Castro C +14 more
europepmc +1 more source
Paroxysmal nocturnal hemoglobinuria masquerading as hemolytic uremic syndrome: a Case Report. [PDF]
Gao M, Liu B, Yao J, Huang F.
europepmc +1 more source
Ravulizumab exposure in early pregnancy. [PDF]
Füreder W, Granser S, Repa A, Farr A.
europepmc +1 more source
C3 mutations and poor pegcetacoplan response in paroxysmal nocturnal hemoglobinuria. [PDF]
Rodríguez de Córdoba S +8 more
europepmc +1 more source

